[iNOVA4Health Seminar] Antibody-Drug Conjugates: Design, Developing Trends and Future Prospects
| When |
04 Dec, 2025
from
12:00 pm to 01:00 pm |
|---|---|
| Where | ITQB NOVA Auditorium |
| Add event to your calendar |
iCal
|
Title: Antibody-Drug Conjugates (ADCs): Design, Developing Trends and Future Prospects
Speaker: John Lambert
Our guest speaker will be Dr. John Lambert, Honorary Professor at The Queen’s University Belfast, Northern Ireland (UK) and Consultant/Scientific Advisor, Cambridge, Massachusetts (USA), a distinguished pioneer in antibody-drug conjugate (ADC) development, instrumental in creating breakthrough therapies such as KADCYLA® (for HER2+ breast cancer), ELAHERE® (for ovarian cancer), and SARCLISA® (for multiple myeloma).
